These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 1497555)

  • 1. Recently characterised autoantibodies and their clinical significance.
    Sturgess A
    Aust N Z J Med; 1992 Jun; 22(3):279-89. PubMed ID: 1497555
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antinuclear antibodies: diagnostic markers for autoimmune diseases and probes for cell biology.
    Tan EM
    Adv Immunol; 1989; 44():93-151. PubMed ID: 2646863
    [No Abstract]   [Full Text] [Related]  

  • 3. Autoantibodies in the diagnosis of systemic rheumatic diseases.
    von Mühlen CA; Tan EM
    Semin Arthritis Rheum; 1995 Apr; 24(5):323-58. PubMed ID: 7604300
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Autoantibodies in collagen diseases].
    Meyer O
    Ann Med Interne (Paris); 1986; 137(8):666-78. PubMed ID: 2436515
    [No Abstract]   [Full Text] [Related]  

  • 5. [Subgroups of connective tissue disease].
    Le Goff P; Youinou P
    Presse Med; 1984 Nov; 13(42):2571-6. PubMed ID: 6239256
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Occurrence of autoantibodies and the clinical course of mixed connective tissue disease, systemic scleroderma, dermatomyositis, polymyositis and Sjögren's syndrome].
    Prokop J; Zietkiewicz E; Słomski R
    Przegl Dermatol; 1986; 73(4):327-31. PubMed ID: 3333867
    [No Abstract]   [Full Text] [Related]  

  • 7. Antinuclear antibodies in diagnosis and management.
    Tan EM
    Hosp Pract (Off Ed); 1983 Jan; 18(1):79-84. PubMed ID: 6401273
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical significance of antinuclear antibodies in systemic rheumatic diseases.
    Hietarinta M; Lassila O
    Ann Med; 1996 Aug; 28(4):283-91. PubMed ID: 8862680
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Differentiation of autoantibodies to extractable nuclear antigens using immunoblotting in various collagen diseases].
    Riemekasten G; Hiepe F
    Z Arztl Fortbild (Jena); 1992 Mar; 86(5):217-22. PubMed ID: 1585674
    [No Abstract]   [Full Text] [Related]  

  • 10. [Spectrum of antinuclear and anti-cytoplasmic antibodies in dermatomyositis and polymyositis overlap syndromes].
    Meurer M; Hausmann-Martinez-Pardo G; Braun-Falco O
    Hautarzt; 1989 Oct; 40(10):623-9. PubMed ID: 2482267
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multiplexed AtheNA multi-lyte immunoassay for ANA screening in autoimmune diseases.
    Shovman O; Gilburd B; Zandman-Goddard G; Yehiely A; Langevitz P; Shoenfeld Y
    Autoimmunity; 2005 Feb; 38(1):105-9. PubMed ID: 15804711
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effective use of autoantibody tests in the diagnosis of systemic autoimmune disease.
    Lyons R; Narain S; Nichols C; Satoh M; Reeves WH
    Ann N Y Acad Sci; 2005 Jun; 1050():217-28. PubMed ID: 16014537
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Autoantibody profile in collagen diseases. A clinical-serological study of 250 patients from Tuebingen clinics].
    von Kiparski A; Stechemesser E; Berg PA
    Dtsch Med Wochenschr; 1986 Aug; 111(33):1234-41. PubMed ID: 3091351
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Autoantibodies to Cytosolic 5'-Nucleotidase 1A in Primary Sjögren's Syndrome and Systemic Lupus Erythematosus.
    Rietveld A; van den Hoogen LL; Bizzaro N; Blokland SLM; Dähnrich C; Gottenberg JE; Houen G; Johannsen N; Mandl T; Meyer A; Nielsen CT; Olsson P; van Roon J; Schlumberger W; van Engelen BGM; Saris CGJ; Pruijn GJM
    Front Immunol; 2018; 9():1200. PubMed ID: 29922285
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Differentiation with immunofluorescence of complement fixing and non-fixing antinuclear factors in patients with and without disseminated lupus erythematosus].
    Peltier AP
    Pathol Biol; 1968 Apr; 16(7):439-44. PubMed ID: 4882383
    [No Abstract]   [Full Text] [Related]  

  • 16. ANAs in systemic rheumatic disease. Diagnostic significance.
    Tan EM; Robinson CA; Nakamura RM
    Postgrad Med; 1985 Sep; 78(3):141-2, 145-8. PubMed ID: 3875842
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Profiles of antinuclear antibodies in systemic rheumatic diseases.
    Notman DD; Kurata N; Tan EM
    Ann Intern Med; 1975 Oct; 83(4):464-9. PubMed ID: 1080976
    [TBL] [Abstract][Full Text] [Related]  

  • 18. IgG subclasses in systemic lupus erythematosus and other autoimmune rheumatic diseases.
    Blanco F; Kalsi J; Ravirajan CT; Speight P; Bradwell AR; Isenberg DA
    Lupus; 1992 Dec; 1(6):391-9. PubMed ID: 1304408
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antibodies to human immunodeficiency virus (HIV-1) in autoimmune diseases: primary Sjögren's syndrome, systemic lupus erythematosus, rheumatoid arthritis and autoimmune thyroid diseases.
    Coll J; Palazon J; Yazbeck H; Gutierrez J; Aubo C; Benito P; Jagiello P; Maldyk H; Marrugat J; Anglada J
    Clin Rheumatol; 1995 Jul; 14(4):451-7. PubMed ID: 7586984
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diagnostic Utility of Separate Anti-Ro60 and Anti-Ro52/TRIM21 Antibody Detection in Autoimmune Diseases.
    Robbins A; Hentzien M; Toquet S; Didier K; Servettaz A; Pham BN; Giusti D
    Front Immunol; 2019; 10():444. PubMed ID: 30915082
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.